GOG-0278

Terminated

Return to Protocol Table

Protocol Information

Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants

Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy with Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (=/<2CM) Cervical Cancer

Principal Investigator

Allan Covens, MD

Status

Terminated

Open to Accrual

October 1, 2012

Closed to Accrual

October 14, 2021

Closed to Accrual & Treatment

October 29, 2021

Complete

March 7, 2025

Terminated

March 7, 2025


Disease Site

Gynecologic [GY] Cervix

Phase

Other

Developmental Therapeutics

No

Primary Objective

To examine the changes before and after non-radical surgical treatment (simple hysterectomy or cone biopsy [fertility preservation]) and pelvic lymphadenectomy) on functional outcomes of bladder, bowel and sexual function for stage IA1 (LVSI+) and IA2-IB1 (<2cm) carcinoma of the cervix.

To evaluate incidence and severity of lymphedema after non-radical surgery (simple hysterectomy or cone biopsy [fertility preservation] and pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2-IB1 (<2cm) carcinoma of the cervix.

Patient Population

Patients with a histologic diagnosis of squamous cell carcinoma, adenocarcinoma or adenosquamous cell carcinoma of the cervix, Stage IA1 (LVSI+), IA2, and IB1 (tumor size [maximum visible or palpable]) ≤ 2cm), any grade.

Target Accrual

220

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.